Dora Kholodenko
Impact in
- Physiology top 0.05%
- Alzheimer's disease research and treatments
- Neurology top 0.5%
- Neuroinflammation and Neurodegeneration Mechanisms
- Barrier Structure and Function Studies
- Parkinson's Disease Mechanisms and Treatments
Papers in
- Physiology 20
- Alzheimer's disease research and treatments 20
-
- Dementia and Cognitive Impairment Research 1
- Co-authors
- Lisa McConlogue (2 shared papers)Kang Hu (2 shared papers)Eliezer Masliah (2 shared papers)Gui-Qiu Yu (2 shared papers)Lennart Mucke (2 shared papers)Gwen P. Tatsuno (2 shared papers)Kelly Johnson‐Wood (3 shared papers)Margaret E. Mallory (1 shared paper)
- Journals
- Alzheimer s & Dementia (3 papers)Journal of Biological Chemistry (2 papers)Nature Medicine (2 papers)Proceedings of the National Academy of Sciences (2 papers)Alzheimer s Research & Therapy (1 paper)
- Partner nations
- IrelandUnited StatesGermany
In The Last Decade
Dora Kholodenko
20 papers receiving 10.4k citations
Dora Kholodenko's Hit Papers
Peers
Comparison fields: 5 of 109
- Physiology 8.6k
- Neurology 888
- Psychiatry and Mental health 1k
- Developmental Neuroscience 109
- Aging 40
Countries citing papers authored by Dora Kholodenko
This map shows the geographic impact of Dora Kholodenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Kholodenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Kholodenko more than expected).
Fields of papers citing papers by Dora Kholodenko
This network shows the impact of papers produced by Dora Kholodenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Kholodenko. The network helps show where Dora Kholodenko may publish in the future.
Co-authors
The 25 scholars most cited alongside Dora Kholodenko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse Hit paper breakdown → | 1999 | 2704 |
| 2 | Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Hit paper breakdown → | 2000 | 1741 |
| 3 | High-Level Neuronal Expression of Aβ1–42in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation Hit paper breakdown → | 2000 | 1626 |
| 4 | Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice Hit paper breakdown → | 1997 | 1115 |
| 5 | Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models Hit paper breakdown → | 1999 | 976 |
| 6 | Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain Hit paper breakdown → | 2001 | 771 |
| 7 | Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease Hit paper breakdown → | 1995 | 616 |
| 8 | 1998 | 400 | |
| 9 | 2003 | 354 | |
| 10 | 1997 | 255 | |
| 11 | 1997 | 159 | |
| 12 | 2008 | 58 | |
| 13 | 2010 | 44 | |
| 14 | 2010 | 44 | |
| 15 | 2013 | 30 | |
| 16 | 2010 | 12 | |
| 17 | 2010 | 6 | |
| 18 | 2010 | 6 | |
| 19 | 1996 | 4 | |
| 20 | Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain | 2000 | 3 |
About Dora Kholodenko
Dora Kholodenko is a scholar working on Physiology, Psychiatry and Mental health, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 21 papers that have together received 10.9k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (20 papers) and Dementia and Cognitive Impairment Research (1 paper). The work is most often cited by research in Physiology (8.6k citations), Neurology (888 citations), Psychiatry and Mental health (1k citations), Developmental Neuroscience (109 citations) and Aging (40 citations). Dora Kholodenko has collaborated with scholars based in Ireland, United States and Germany. Frequent co-authors include Lisa McConlogue, Kang Hu, Eliezer Masliah, Gui-Qiu Yu, Lennart Mucke, Gwen P. Tatsuno, Kelly Johnson‐Wood, Margaret E. Mallory, Edward M. Rockenstein and Peter A. Seubert. Their work appears in journals such as Alzheimer s & Dementia, Journal of Biological Chemistry, Nature Medicine, Proceedings of the National Academy of Sciences and Alzheimer s Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.